| pubmed-article:10024133 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10024133 | lifeskim:mentions | umls-concept:C0021760 | lld:lifeskim |
| pubmed-article:10024133 | lifeskim:mentions | umls-concept:C0220931 | lld:lifeskim |
| pubmed-article:10024133 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:10024133 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:10024133 | lifeskim:mentions | umls-concept:C0410158 | lld:lifeskim |
| pubmed-article:10024133 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10024133 | pubmed:dateCreated | 1999-3-24 | lld:pubmed |
| pubmed-article:10024133 | pubmed:abstractText | To address the question of whether the increased plasma concentration of interleukin 6 (IL-6) following strenuous muscular work could be related to exercise-induced muscle damage, 5 moderately active male volunteers underwent two isokinetic exercise sessions in the eccentric mode, separated by a period of 3 weeks during which the subjects underwent five training sessions. Before training, exercise was followed by severe muscle pain (delayed-onset muscle soreness; DOMS), and by significant increases in plasma IL-6 level and serum myoglobin concentration (SMb) (P < 0.001). After training, postexercise DOMS and SMb values were significantly lower than those measured before training. There was no significant difference between plasma IL-6 levels measured at the same time points before and after training. We conclude that the hypothetical relationship between exercise-induced muscle damage and increased postexercise levels of circulating IL-6 is not substantiated by the present results. | lld:pubmed |
| pubmed-article:10024133 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10024133 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024133 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10024133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024133 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10024133 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10024133 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10024133 | pubmed:issn | 0148-639X | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:LangBB | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:DebyCC | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:Juchmès-Ferir... | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:DuchateauJJ | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:Deby-DupontGG | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:CrielaardJ... | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:CamusGG | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:CroisierJ LJL | lld:pubmed |
| pubmed-article:10024133 | pubmed:author | pubmed-author:VennemanII | lld:pubmed |
| pubmed-article:10024133 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10024133 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:10024133 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10024133 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10024133 | pubmed:pagination | 208-12 | lld:pubmed |
| pubmed-article:10024133 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:meshHeading | pubmed-meshheading:10024133... | lld:pubmed |
| pubmed-article:10024133 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10024133 | pubmed:articleTitle | Effects of training on exercise-induced muscle damage and interleukin 6 production. | lld:pubmed |
| pubmed-article:10024133 | pubmed:affiliation | Department of Physical Medicine and Rehabilitation, University of Liège, Sart Tilman, Belgium. | lld:pubmed |
| pubmed-article:10024133 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10024133 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10024133 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024133 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024133 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024133 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10024133 | lld:pubmed |
